Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2004;43:154-155
Published online before print December 15, 2003, doi: 10.1161/01.HYP.0000109870.99110.7e
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
43/2/154    most recent
01.HYP.0000109870.99110.7ev1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grassi, G.
Right arrow Articles by Mancia, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grassi, G.
Right arrow Articles by Mancia, G.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure
Related Collections
Right arrow Clinical Studies
Right arrow Autonomic, reflex, and neurohumoral control of circulation

(Hypertension. 2004;43:154.)
© 2004 American Heart Association, Inc.


Editorial Commentaries

Neurogenic Hypertension: Is the Enigma of Its Origin Near the Solution?

Guido Grassi; Giuseppe Mancia

From the Clinica Medica, Dipartimento di Medicina Clinica, Prevenzione e Biotecnologie Sanitarie, Università Milano-Bicocca, Monza (Milano), Centro Interuniversitario di Fisiologia Clinica e Ipertensione and Centro Auxologico Italiano, Milano, Italy.

Correspondence to Professor Guido Grassi, Clinica Medica, Ospedale S. Gerardo dei Tintori, Via Donizetti 106, 20052 Monza (MI), Italia. E-mail guido.grassi@unimib.it


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Since the demonstrationthat the sympathetic nervous system exerts a fundamental role in the homeostatic control of blood pressure, the hypothesis has been advanced that abnormalities in the adrenergic regulation of either cardiac output or peripheral vascular resistance might represent the pathophysiological hallmarks of the essential hypertensive state of "neurogenic" nature. To date, the evidence supporting this hypothesis can be summarized as follows. First, the early stages of hypertension frequently display hyperkinetic circulation characterized by an increase in cardiac output coupled with an elevated heart rate (ie, by hemodynamic abnormalities that have been shown to be triggered by a blunted parasympathetic and an enhanced sympathetic cardiovascular drive).1 Second, a meta-analysis of all published studies that have made use of plasma norepinephrine assay for evaluating adrenergic tone has provided evidence that, even accounting for some negative results, an indirect marker of the sympathetic function, such as plasma norepinephrine, is significantly elevated in essential hypertensive patients as compared with age-matched normotensive controls.2 Third, by using the technique based on the intravenous tracer infusion of small doses of radiolabeled norepinephrine, it has been possible to show3 that the rate of norepinephrine spillover from the sympathetic neuroeffector junctions is augmented in young subjects with borderline blood pressure elevation and that this enhanced release is particularly manifest in the kidney and in the heart (ie, in two organs of key importance in the homeostatic process of blood pressure control). Fourth, hypertensive patients display at the 123I-metaiodobenzylguanidine cardiac imaging technique a lower uptake and a greater washout . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
FASEB J.Home page
H. Li, Y. Gao, Y. Qi, M. J. Katovich, N. Jiang, L. N. Braseth, D. A. Scheuer, P. Shi, and C. Sumners
Macrophage migration inhibitory factor in hypothalamic paraventricular nucleus neurons decreases blood pressure in spontaneously hypertensive rats
FASEB J, September 1, 2008; 22(9): 3175 - 3185.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
G. Grassi, F. Quarti-Trevano, and G. Mancia
Review: Cardioprotective effects of telmisartan in uncomplicated and complicated hypertension
Journal of Renin-Angiotensin-Aldosterone System, June 1, 2008; 9(2): 66 - 74.
[Abstract] [PDF]


Home page
J EndocrinolHome page
A L Markel, O E Redina, M A Gilinsky, G M Dymshits, E V Kalashnikova, Y. V Khvorostova, L A Fedoseeva, and G S Jacobson
Neuroendocrine profiling in inherited stress-induced arterial hypertension rat strain with stress-sensitive arterial hypertension
J. Endocrinol., December 1, 2007; 195(3): 439 - 450.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. Grassi
Qualitative Assessment of Sympathetic Neural Drive in Cardiometabolic Disease: A New Challenge
Hypertension, November 1, 2007; 50(5): 835 - 836.
[Full Text] [PDF]


Home page
HypertensionHome page
G. Grassi
Adrenergic Overdrive as the Link Among Hypertension, Obesity, and Impaired Thermogenesis: Lights and Shadows
Hypertension, January 1, 2007; 49(1): 5 - 6.
[Full Text] [PDF]


Home page
HypertensionHome page
D. A. Heaton, M. Lei, D. Li, S. Golding, T. A. Dawson, R. M. Mohan, and D. J. Paterson
Remodeling of the Cardiac Pacemaker L-Type Calcium Current and Its {beta}-Adrenergic Responsiveness in Hypertension After Neuronal NO Synthase Gene Transfer
Hypertension, September 1, 2006; 48(3): 443 - 452.
[Abstract] [Full Text] [PDF]